Wednesday 8 July 2015

Miguel Iglesais of Questel

Miguel Iglesias
Miguel Iglesias
Director, Questel
LINKS

With Miguel iglesais, Director, Questel USA (First pic) ........Attending Questel's Workshop on "Align innovation with your IP strategy" at Hilton hotel, Sahar, Mumbai, India.........workshop organised by Questel Orbit Inc. USA on July 08, 2015
 Some pics 


 


Experience




Sales Manager

Questel Orbit

 – Present (13 years)Alexandria, VA






Orbit IP Searching


Round body
Web based professional patent search software integrating Questel’s unique global patent family database with powerful search and review tools.
Access is available for a fixed annual fee based on the number of users.



MAIN FEATURES


Hitlist with legal status timeline preview
Compact Hitlist by descending relevance

Find relevant patents

Orbit IP Search offers the power of Questel’s legendary search engine to search efficiently the largest high value added database collection in the industry;
  • The largest and most refined set of search options such as prefix, midfix, suffix, proximities, Booleans, and any more
  • Consistent and sharp results count
  • Bibliographic patent collections from 100+ authorities
  • Full text collections from 20+ authorities
  • Exclusive invention based family structure: Search across all members as a single record
  • High quality English language translations: Search across all languages from a single search screen
  • Key content:
    • Object
    • Advantages and prior art drawbacks
    • Independent claims
  • Normalized assignee names
  • Enhanced and normalized legal status
  • Normalized technical concepts
  • Daily updatesfrom major patenting authorities
    • All major classification systems: IPC, CPC, F-Terms, FI-Terms, USPCL
    • Industry leading similarity search

Scanning with interactive highlighting & high resolution
Hitlist of image mosaics with key weighted technical

Select key art

The Orbit review interface has been tailored to provide a quick way to target relevant patent families, thanks to the Computer Assisted Reading features:
  • The built-in auto-ranking displays patent families in a descending order of relevance
  • Similarity ranking, resulting from a similarity search, uses best practice to present patents by descending order of similarity
  • Unique invention based family structure, cuts down results lists to one record per unique invention
  • Key content summaries, provide a swift review of lengthy patent text
  • Legal status display & timeline; provides insight to a patent family’s legal status, ‘at a glance’
  • Key Words In Context (KWIC) reviews offer efficient scanning of each term
  • Normalized key technical concepts clouds highlight weighted key concepts
  • High resolution mosaics of images provide a unique hitlist browsing option
  • Scanning of interactive highlighted terms allows to spot proximity at a glance and go to relevant sections right away.
  • Dynamic family graphs bring to light hidden complex relationship between members
  • Citation graphs efficiently show and focus on the most relevant ones

Patent family view with user defined fields
Run statistical analysis on your own portfolio

Manage

The Orbit Workfiles allow to collect all patent and design portfolios on a collaborative platform where knowledge can be built and shared across your company and partners:
  • Annotate saved patent families, create an internal knowledge base:
    • Attach documents
    • Rank inventions
    • Classify your portfolio
    • Share all or sections of your archives
    • Search across all stored patents, including customized meta data
    • Analyze your archives using an extensive choice of parameters, including customized meta data
  • Monitor your market by setting up regular alerts regarding the publication of new patent families and/or legal status updates. Alert results can feed saved foldersand be integrated into workflows allowing for distribution and collection of feedback from colleagues.

Orbit IP Business Intelligence


Orbit IPBI
Web based patent analysis software integrating the Orbit Prior Art search module with a powerful suite of patent analysis visualisations, designed to give answers to key business questions. Access is available for a fixed annual fee based on the number of users and patent volumes required for analysis. 
You are a Patent Analyst, IP Manager, Marketing Executive, Business Developer, CTO, CEO

What do you need to do?




Other IP Business Intelligence features

Patent data contains unrivalled business intelligence information. There are now over 2 million patent applications per year and each application represents a significant investment in a documented and classified technology area.

Orbit IP Business Intelligence provides the tools needed to unlock the business insight hidden in global patent data:
  1. Unique normalised data source; 100+ patent authorities, unique invention based family structure, normalised assignees, enhanced legal status data.
  2. Lightning fast processing times; transform data sets of over 1 million patent families into graphs in seconds.
  3. Active data interrogation; click on any point on any graph to view the source data detail behind the big picture.
  4. Custom data normalisation options; create custom normalisation rules merging related companies, technologies and inventors into simple groups.
  5. Award winning graphical representations.

Main features from Orbit IPBI


Company Analysis

Company analysis

  • Visualise technological strengths
  • View technology investment trends
  • Identify key innovative employees
  • Visualise key geographical markets

Technology Analysis

Technology analysis

  • Identify the key players
  • View investment acceleration over time
  • Find potential licensing partners
  • Identify litigation threats
  • Compare ideas with existing technology

Company Comparison

Company comparisons

  • How do technology specialities overlap?
  • Who entered the market first?
  • How do investment rates in competing technology areas compare over time?
  • What is the litigation landscape?

Fast Visual Prior art Search

Fast visual prior art searches

  • Cut down large result sets in minutes
  • Visualise related key technology concepts
  • Spot new search terms, concepts, classifications
  • Identify co-assignment & citations trends

OFFICES

QUESTEL OFFICES in the WORLD

Paris, France (Headquarters)
1 Blvd de la Madeleine
75001 Paris
Phone: +33 (0)1 55 04 52 00
Fax: +33 (0)1 55 04 52 01


Sophia-Antipolis, France (R&D)
930, route des Dolines
06560 Valbonne, France
or
BP 239
06904 Sophia-Antipolis Cedex
Phone: +33 (0)4 92 94 55 55
Fax: +33 (0)4 92 94 55 56


Alexandria, VA (U.S. Main Office)
2331 Mill Road - Suite 600
Alexandria, VA 22314
Phone : +1 (703) 519 1820
Help Desk : 800 456 7248
Fax : +1-844-QUESTEL
( +1-844-7837835)


Tokyo, Japan
Questel Liaison Office for Japan,
10-9-204 Shinsen-cho, Shibuya-ku,
Tokyo 150-0045
Phone: +81 90 4679 0709
Fax: +81 3 6823 8704


Shanghai, China
科知信思信息服务(上海)有限公司。
21st Floor, 168 Yin Cheng Zhong Road, Bank of Shanghai Tower, Pudong Shanghai 200120, CHINA
中国上海浦东银城中路
168号上海银行大厦21楼 邮编:200120
Customer support: +86 21 51167212
Phone: +86 21 51167213
Fax: +86 21 51167116


Some more pics

New Patent Analysis Tools Coming to Orbit.com | The Intellogist Blog
intellogist.wordpress.com
Patent map (screenshot from PowerPoint).


Solution - Lpines.com - Technology transfer and ventures | Lpines ...
lpines.com
(Questel Orbit)

New Patent Analysis Tools Coming to Orbit.com | The Intellogist Blog
intellogist.wordpress.com
Pick a chart type (screenshot from workshop PowerPoint presentation).



Innovation Software: Orbit Innovation Capture
www.ideaconnection.com
Orbit Innovation Capture



Drilling down through a tree map (screenshot from PowerPoint).









.................
DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO …..FOR BLOG HOME CLICK HERE

Join me on Linkedin

View Anthony Melvin Crasto Ph.D's profile on LinkedIn

Join me on Facebook FACEBOOK
Join me on twitterFollow amcrasto on Twitter
Join me on google plus Googleplus

 amcrasto@gmail.com

09b37-misc2b027LIONEL MY SON
He was only in first standard in school when I was hit by a deadly one in a million spine stroke called acute transverse mylitis, it made me 90% paralysed and bound to a wheel chair, Now I keep him as my source of inspiration and helping millions, thanks to millions of my readers who keep me going and help me to keep my son happy


Thursday 25 June 2015

Council of Scientific and Industrial Research (India), WO 2015087352, process for the synthesis of aryl sulfones

logo
WO-2015087352
 process for the synthesis of aryl sulfones
The present patent discloses a novel, efficient and transition-metal-free room temperature single step process for synthesis of aryl sulfones and substituted aryl sulfones starting from aryl substrates.
Baburao Mhaske, Santosh; Pandya, Virat

                           


Novel and transition-metal-free, room temperature, single step process for preparing aryl sulfones and substituted aryl sulfones.

Aryl sulfones are useful as intermediates in the synthesis of drugs eg rofecoxib and laropiprant; while substituted aryl sulfones possess anticancer and anti-HIV activities.
Rofecoxib.svgROFECOXIB


Laropiprant.pngLAROPRIPRANT


see WO2014024212 (listing Santosh Baburao Mhaske as one of the inventors), claiming a similar one-pot synthesis of aryl phosphorous compounds.

Also see Org Lett, Jul 2014, for an article, covering the theme of invention.


WO2014024212
http://www.google.com/patents/WO2014024212A1?cl=en



Figure imgf000004_0001



Example 1: General Experimental Procedure for the Phosphorylation:
To a flame dried two-neck round-bottom flask containing CsF (5.50 equiv.) was added o-silyl aryl triflate (II) (1.00 equiv.) in acetonitrile, followed by addition of phosphorous compound of formula (III) (4.00 equiv.) in acetonitrile under argon atmosphere. The reaction mixture was stirred at room temperature and the progress was monitored by TLC. After completion of the reaction, acetonitrile was removed on rotary evaporator and the crude product was dried under high vacuum and purified by flash silica gel column using a gradient of ethyl acetate-petroleum ether to afford corresponding aryl-phosphorous compounds of formula (I) in good to excellent yields.
Example 2: Synthesis of diethyl phenylphosphonate (1)
To a stirred solution of CsF (Cesium Fluoride, 1.4 g, 9.22 mmol) in anhydrous acetonitrile (5 mL) was consecutively added o-trimethylsilyl phenyl triflate (500 mg, 1.67 mmol) and triethyl phosphite (1.12 g, 6.71 mmol). Reaction mixture was allowed to stir at room temperature (30 °C) for 20 hrs. The reaction mixture was concentrated and directly loaded on silica gel column and purified by using solvent gradient of Pet. EthenEthyl Acetate (1 : 1) to yield a colourless liquid phosphonate 1 (345 mg, 96%).
Figure imgf000016_0001
Reaction Time: 20 h, Rf. 0.4 (1 : 1 EtOAc:Pet. Ether); Thick oil; 345 mg, 96 %; Ή NMR (400 MHz, CDC13, TMS) δ 7.88-7.77 (m, 2H), 7.60-7.52 (m, 1H), 7.51 -7.43 (m, 2H), 4.22-4.02 (m, 4H), 1.33 (t, J= 7.2 Hz, 6H); 13C NMR (100 MHz, CDC13, TMS) δ 132.3 (d, J= 2.3 Hz), 131.7 (d, J= 10.0 Hz), 128.4 (d, J = 14.6 Hz), 128.3 (d, J = 188.0 Hz), 62.0 (d, J= 5.4 Hz), 16.3 (d, J = 6.2 Hz); 31P NMR (162 MHz, CDC13) δ 18.8; Mass (M+Na)+ 237; Known compound, Lit. M. Kalek, A. Ziadi, J. Stawinski, Org. Lett. 2008, 10, 4637. Example 3: Synthesis of dimethyl phenylphosphonate (2)
To a stirred solution of CsF (112 mg, 0.74 mmol) in anhydrous acetonitrile was consecutively added o-trimethylsilyl phenyl triflate (40 mg, 0.13 mmol) and trimethyl phosphite (67 mg, 0.53 mmol). Reaction mixture was allowed to stir at room temperature (30 °C) for 16 hrs. The reaction mixture was concentrated and directly loaded on silica gel column and purified by using solvent gradient of Pet. EthenEthyl Acetate (1 : 1) to yield a colourless liquid phosphonate 2 (22 mg, 90%).
Figure imgf000017_0001
Reaction Time: 16 h; Rf. 0.4 (1 :1 EtOAc:Pet. Ether); Thick oil; 22.0 mg, 90%; Ή NMR (500 MHz, CDC13, TMS) δ 7.80 (dd, J = 8.2, 13.4 Hz, 2H), 7.60-7.55 (m, 1H), 7.51-7.46 (m, 2H), 3.78 (s, 3H), 3.76 (s, 3H); 1 C NMR (125 MHz, CDC13, TMS) δ 132.6 (d, J= 2.9 Hz), 131.8 (d, J = 9.5 Hz), 128.5 (d, J = 15.3 Hz), 126.9 (d, J = 188.8), 52.6 (d, J = 5.7 Hz); 3,P NMR (162 MHz, CDCI3) δ 21.7; Mass (M + Na)+ 209; Known compound, Lit. M. Kalek, A. Ziadi, J. Stawinski, Org. Lett. 2008, 10, 4637.
Example 4: Dibutyl phenylphosphonate (3)
Figure imgf000017_0002
2-(trimethylsilyl)phenyl trifluoromethanesulfonate (25 mg, 0.083 mmol), Cesium Fluoride (70 mg, 0.461 mmol), Tributyl phosphite (83 mg, 0.335 mmol), Acetonitrile (1 ml): Reaction Time: 24 h; Rf. 0.4 (1:3 EtOAc:Pet. Ether); Thick oil; 16.3 mg, 72 %; Ή NMR (400 MHz, CDC13, TMS) δ 7.80 (dd, 7= 6.8, 13.3 Hz, 2H), 7.55 (t, J= 7.5 Hz, 1H), 7.50-7.42 (m, 2H), 4.12-3.95 (m, 4H), 1.65 (quint, J = 7.3 Hz, 4H), 1.39 (sext, J = 7.3 Hz, 4H), 0.9 (t, J = 7.3 Hz, 6H); 13C NMR (100 MHz, CDCl3, TMS) 6 132.3 (d, J= 3.1 Hz), 131.7 (d, J= 9.3 Hz), 128.4 (d, J = 15.4 Hz), 128.3 (d, J = 187.3 Hz), 65.8 (d, J = 5.4 Hz), 32.4 (d, J = 6.9 Hz), 18.7, 13.6; 31P NMR (162 MHz, CDCI3) δ 18.8; Mass (M + Na)+ 293; Known compound, Lit. X. Lu, J. Zhu, Synthesis 1987, 8, 726.
Example 5: Diethyl 2,5-dimethylphenylphosphonate (4):
Figure imgf000017_0003
3,6-dimethyl-2-(trimethylsilyl)phenyl trifluoromethanesulfonate (25mg, 0.076 mmol), Cesium Fluoride (64 mg, 0.421 mmol), Triethtyl phosphite (50 mg, 0.306 mmol), Acetonitrile (1 ml): Reaction Time: 35 h; Rf. 0.3 (1 :4 EtOAc:Pet Ether); Thick oil; 16.1 mg, 87 % ; Ή NMR (400 MHz, CDC13, TMS) δ 7.75 (d, J = 14.8, 1 H), 7.23 (d, J = 7.8 Hz, 1 H), 7.17-7.10 (m, 1H), 4.21-4.00 (m, 4H), 2.52 (s, 3H), 2.34 (s, 3H), 1.33 (t, J = 7.3 Hz, 6H); 13C NMR (100 MHz, CDCI3, TMS) 8 138.5 (d, J = 10.0 Hz), 134.9 (d, J = 14.6 Hz), 134.5 (d, J = 10.8 Hz), 133.2, 131.1 (d, 7 = 15.4 Hz), 126.3 (d, J = 182.7 Hz), 61.8 (d, J = 5.4 Hz), 20.7, 20.6, 16.3 (d, = 6.2 Hz); 31P NMR (162 MHz, CDC13) 6 20.0; Mass (M + Na)+ 265; Known Compound, Lit. S. Branion, V. Benin, Synth.Commun. 2006, 36, 2121.
Example 6: Diethyl 3-methoxyphenylphosphonate (5):
Figure imgf000018_0001
3-methoxy-2-(trimethylsilyl)phenyl trifluoromethanesulfonate (25 mg, 0.076 mmol), Cesium Fluoride (63 mg, 0.419 mmol), Triethtyl phosphite (50 mg, 0.304 mmol), Acetonitrile (1 ml): Reaction Time: 24 h; Rf. 0.3 (2:3 EtOAc:Pet Ether); Thick oil; 13.7 mg, 74 %; Ή NMR (200 MHz, CDCI3, TMS) δ 7.45-7.28 (m, 3H), 7.15-7.01 (m, 1H), 4.25-3.96 (m, 4H), 3.85 (s, 3H),
I .33 (t, J = 7.1 Hz, 6H); 13C NMR (100 MHz, CDC13, TMS) δ 159.4 (d, J= 18.5 Hz), 129.7 (d, J = 17.7 Hz), 129.6 (d, J= 187.3 Hz), 124.0 (d, J = 9.3 Hz), 1 18.8 (d, 7= 3.1 Hz), 1 16.4 (d, J =
I I .6 Hz), 62.2 (d, J = 5.4 Hz), 55.41, 16.3 (d, J = 6.2 Hz); 31P NMR (162 MHz, CDC13) δ 18.7; Mass (M + Na)+ 267; Known Compound, Lit. G. Yang, C. Shen, L. Zhang, W. Zhang. Tetrahedron Lett. 2011, 52, 5032.
Example 7: Diethyl benzo[d] [l,3]dioxol-5-ylphosph0nate (6):
Figure imgf000018_0002
6-(trimethylsilyl)benzo[d][l,3]dioxol-5-yl trifluoromethanesulfonate (25 mg, 0.073 mmol), Cesium Fluoride (61 mg, 0.402 mmol), Triethtyl phosphite (48 mg, 0.292 mmol), Acetonitrile (1 ml): Reaction Time: 16 h; Rf. 0.3 (2:3 EtOAc:Pet Ether); Thick oil; 16.0 mg, 85 %; Ή NMR (500 MHz, CDCI3, TMS) δ 7.38 (dd, J = 7.9, 14.0 Hz, 1H), 7.20 (d, J = 12.8 Hz, 1H), 6.88 (dd, J = 3.4, 7.6 Hz, 1H), 6.03 (s, 2H), 4.17-4.01 (m, 4H), 1.32 (t, J = 7.0 Hz, 6H); , C NMR (100 MHz, CDC13) TMS) 5151.2 (d, J = 2.9 Hz), 147.8 (d, J= 22.9 Hz), 127.4 ( d, J= 11.4 Hz), 121.3 (d,J= 193.6 Hz), 111.2 (d,/= 12.4Hz), 108.6 (d,J= 18.1 Hz), 101.5, 62.0 (d,J=5.7 Hz), 16.3 (d, J= 6.7 Hz); 3IP NMR (162 MHz, CDC13) δ 19.0 ; Mass (M + Na)+ 281; Known Compound, Lit. G. Yang, C. Shen, L. Zhang, W. Zhang. Tetrahedron Lett.2011, 52, 5032. Example 8: Diethyl 3,4-difluorophenylphosphonate (7):
Figure imgf000019_0001
4,5-difluoro-2-(trimethylsilyl)phenyl trifluoromethanesulfonate (25 mg, 0.078 mmol), Cesium Fluoride (62 mg, 0.411 mmol), Triethtyl phosphite (50 mg, 0.299 mmol), Acetonitrile (1 ml): Reaction Time 4 h; Rf: 0.5 (2:3 EtOAc:Pet Ether); Thick oil; 14.6 mg, 78 %; Ή NMR (500 MHz, CDC13> TMS) δ 7.67-7.55 (m, 2H), 7.31-7.23 (m, 1H), 4.21-4.05 (m, 4H), 1.34 (t, J= 7.0 Hz, 6H); 13C NMR (125 MHz, CDC13, TMS) 6153.1 (ddd, J= 3.8, 12.4, 255.6 Hz), 150.2 (ddd, J= 13.4, 22.9, 252.7 Hz), 128.8 (ddd, J= 3.8, 6.7, 10.5 Hz) 125.9 (dt, J= 3.8, 192.7 Hz), 121.1 (dd,J= 11.4, 18.1 Hz), 117.9 (t,J= 18.1 Hz), 62.4 (d, J= 4.8 Hz), 16.2 (d, J= 5.7 Hz) 3,P NMR (162 MHz, CDC13) δ 15.8 (apparent t, JPF = 6.1 Hz); HRMS-ESI (m/z) calcd (CioH,3F203P + H)+: 251.0643 found: 251.0643.
Example 9: Dimethyl 3,4-difluorophenylphosphonate (8): O
F^^P(OMe)2
4,5-difluoro-2-(trimethylsilyl)phenyl trifluoromethanesulfonate (25 mg, 0.074 mmol), Cesium Fluoride (62 mg, 0.411 mmol), Trimethtyl phosphite (37 mg, 0.299 mmol), Acetonitrile (1 ml): Reaction Time: 4 h; Rf.0.4 (1:3 EtOAc:Pet Ether); Thick oil; 11.8 mg, 71 %; Ή NMR (400 MHz, CDC13, TMS) S 7.67-7.53 (m, 2H), 7.34-7.24 (m, 1H), 3.79 (s, 3H), 3.77 (s, 3H); 13C NMR (100 MHz, CDC13, TMS) δ 153.3 (ddd, J = 3.9, 12.3, 256.6 Hz), 150.3 (ddd, J= 12.3, 22.4, 252.0 Hz), 129.0 (ddd, J= 3.9, 6.9, 10.8 Hz), 124.2 (dt,J=3.9, 193.4 Hz), 121.3 (dd,J = 11.6, /= 18.5 Hz), 118.0 (t, J= 17.7 Hz), 52,9 (d, J= 6.2 Hz);31P NMR (162 MHz, CDC13) δ 18.6 (d, JpF = 7.5 Hz); HRMS-ESI (m/z) calcd (C8H9F203P + H)+: 223.0330 found: 223.0335.
Example 10: Diethyl naphthalen-2-ylphosphonate (9):
Figure imgf000020_0001
l-(trimethylsilyl)naphthalen-2-yl trifluofomethanesulfonate (25 mg, 0.073 mmol), Cesium Fluoride (60 mg, 0.395 mmol), Triethtyl phosphite (47 mg, 0.287 mmol), Acetonitrile (1 ml): Reaction Time 24 h; Rf: 0.3 (1 :3 EtOAc:Pet. Ether); Thick oil; 15.5 mg, 82 %; Ή NMR (400 MHz, CDC13, TMS) δ 8.44 (d, J = 15.6 Hz, 1H), 7.97-7.85 (m, 3H), 7.81-7.72 (m, 1H), 7.64- 7.52 (m, 2H), 4.26-4.05 (m, 4H), 1.34 (t, J= 7.0 Hz, 6H); 13C NMR (100 MHz, CDC13, TMS) δ 135.0 (d, J = 2.3 Hz), 134.0 (d, /= 10.0 Hz), 132.3 (d, J = 16.2 Hz), 128.9, 128.3 (d, J = 14.7 Hz), 128.2, 127.8, 126.8, 126.4 (d, J = 9.2 Hz), 125.3 (d, J = 188.1 Hz), 62.1 (d, J = 5.4 Hz), 16.3 (d, J = 6.2 Hz); 31P NMR (162 MHz, CDC13) δ 19.1 ; Mass (M + Na)+ 287; Known compound, Lit. M. Kalek, A. Ziadi, J. Stawinski, Org. Lett. 2008, 10, 4637.
Example 11: Synthesis of ethyl diphenylphosphinate (10) To a stirred solution of CsF (70 mg, 0.46 mmol) in anhydrous acetonitrile (1 mL) was consecutively added o-trimethylsilyl phenyl inflate (25 mg, 0.08 mmol) and diethyl phenyl phosphonite (66 mg, 0.33 mmol). Reaction mixture was allowed to stir at room temperature (30 °C) for 24 hrs. The reaction mixture was concentrated and directly loaded on silica gel column and purified by using solvent gradient of Pet. EthenEthyl Acetate (1 : 1) to yield a colourless liquid phosphinate (15.7 mg, 76%).
Figure imgf000020_0002
Reaction Time: 24 h; Rf: 0.3 (1 : 1 EtOAc:Pet Ether); Thick oil; 15.7 mg, 76 %; Ή NMR (400
MHz, CDC13) TMS) δ 7.87-7.77 (m, 4H), 7.55-7.48 (m, 2H), 7.47-7.39 (m, 4H), 4.1 1 (apparent quint, J = 7.1 Hz, 2H), 1.37 (t, J = 7.1 Hz, 3H); 13C NMR ( 100 MHz, CDC13, TMS) 5 132.0 (d, J = 2.1 Hz), 131.6 (d, J = 136.4 Hz), 131.5 (d, J = 10.1 Hz), 128.4 (d, J = 13.1 Hz ), 61.1 (d, J = 5.4 Hz), 16.4 (d, J = 6.2 Hz); 31 P NMR (162 MHz, CDC13) 8 31.3; HRMS-ESI (m/z) calcd (CMH,502P + H)+ : 247.0882 found: 247.0886; Known compound, Lit. C. Huang, X. Tang, H. Fu, Y. Jiang, Y. Zhao, J. Org. Chem. 2006, 71, 5020.
Example 12: Ethyl (2,5-dimethylphenyl)(phenyl)phosphinate (11):
Figure imgf000021_0001
3,6-dimethyl-2-(trimethylsilyl)phenyl trifluoromethanesulfonate (25 mg, 0.077 mmol), Cesium Fluoride (64 mg, 0.421 mmol), Diethyl phenylphosphonite (60 mg, 0.306 mmol), Acetonitrile (1 ml): Reaction Time: 32 h; Rf. 0.4 (1 : 1 EtOAc:Pet Ether); Thick oil; 13.0 mg, 62 %; Ή NMR (400 MHz, CDC13, TMS) δ 7.81 -7.70 (m, 3H), 7.52-7.40 (m, 3H), 7.23 (d, J = 7.8 Hz, 1H), 7.12-7.05 (m, 1H), 4.11 (apparent quint, J = 7.0 Hz, 2H), 2.36 (s, 3H), 2.33 (s, 3H), 1.38 (t, J = 7.0 Hz, 3H); ,3C NMR (100 MHz, CDC13, TMS) 5 138.6 (d, J = 10.8 Hz), 135.0 (d, J = 12.3 Hz), 133.9 (d, J = 9.3 Hz), 132.5 (d, J = 124.1 Hz), 128.4 (d, J = 13.4 Hz ), 131.7, 131.5 (d, J = 7.7 Hz), 131.4, 131.3, 129.0 (d, J = 133.3 Hz), 128.4 (d, J = 13.1Hz), 60.7 (d, J= 5.4 Hz), 20.9, 20.7 (d, J = 3.9 Hz), 16.4 (d, J = 6.9 Hz); 3 IP NMR (162 MHz, CDC13,) δ 32.2; HRMS-ESI (m/z) calcd (β,6Η,9θ2Ρ + H)+ : 275.1 195 found: 275.1 193.
Example 13: (2,5-dimethylphenyl)diphenylphosphine oxide (12)
To a stirred solution of CsF (63 mg, 0.42 mmol) in anhydrous acetonitrile 1 mL was consecutively added 2,5 dimethyl -(o-trimethyl silyl)phenyl triflate (25 mg, 0.077 mmol) and ethoxydiphenylphosphine (60 mg, 0.31 mmol). Reaction mixture was allowed to stir at room temperature (30 °C) for 30 hrs. The reaction mixture' was concentrated and directly loaded on silica gel column and purified by using solvent gradient of Pet. EthenEthyl Acetate (1 : 1) to yield a white solid phosphine oxide (19 mg, 81%).
Figure imgf000022_0001
Reaction Time: 30 h; Rf: 0.3 (1 : 1 EtOAc:Pet Ether); White Solid; mp 157-159 °C; 19.0 mg, 81 %; 1 H NMR (400 MHz, GDC13, TMS) δ 7.75-7.60 (m, 4H), 7.59-7.52 (m, 2H), 7.51-7.43 (m, 4H), 7.26-7.20 (m, 1H), 7.19-7.13 (m, 1H), 6.88 (d, J = 14.4 Hz, 1H), 2.37 (s, 3H), 2.21 (s, 3H); 13C NMR ( 100 MHz, CDCI3, TMS) 5 140.0 (d, J = 7.7 Hz), 134.7 (d, J = 13.1 Hz), 133.9 (d, J = 12.3 Hz), 132.9 (d, J = 103.3 Hz), 132.8 (d, J = 2.3 Hz), 13Ί .9 (d, J = 10.0 Hz), 131.8, 131.7 (d, J = 3.1 Hz), 130.4(d, J= 103.3 Hz), .128.5 (d, J = 11.6 Hz), 21.2 (d, J = 4.6 Hz), 21.0; 31P NMR ( 162 MHz, CDCI3) δ 31.7; HRMS-ESI (m/z) calcd (C20H19OP + H)+ : 307.1246 found: 307.1244. Example 14: Synthesis of (3-methoxyphenyl)diphenylphosphine oxide (13)
To a stirred solution of CsF (64 mg, 0.42 mmol) in anhydrous acetonitrile was consecutively added 2-methoxy (o-trimethyl silyl) phenyl triflate (25 mg, 0.077 mmol) and ethoxydiphenylphosphine (61 mg, 0.31 mmol). Reaction mixture was allowed to stir at room temperature (30 °C) for 20 hrs. The reaction mixture was concentrated and directly loaded on silica gel column and purified by using solvent gradient of Pet. EthenEthyl Acetate (1 : 1) to yield a white sticky solid phosphine oxide (16 mg, 68%).
Figure imgf000022_0002
Reaction Time: 20 h; Rf. 0.3 (1 : 1 EtOAc:Pet Ether); Thick oil; 16.0 mg, 68 %; Ή NMR (400 MHz, CDC13, TMS) δ 7.71-7.63 (m, 4H), 7.59-7.52 (m, 2H), 7.50-7.43 (m, 4H), 7.40-7.29 (m, 2H), 7.18-7.05 (m, 2H), 3.80 (s, 3H); 13C NMR (100 MHz, CDC13, TMS) δ 159.6 (d, / = 15.4 Hz), 133.8 (d, 7 = 103.3 Hz), 132.4 (d, J = 104.0 Hz), 132.1 (d, J = 10.0 Hz), 131.9 (d, J = 3.1 Hz), 129.6 (d, J= 14.6 Hz), 128.5 (d, J= 12.3 Hz), 124.4 (d, J= 10.0 Hz), 1 18.2 (d, J= 3.1 Hz), 1 16.7 (d, J = 10.8 Hz), 55.4; 31P NMR (162 MHz, CDC13) δ 29.5; HRMS-ESI (m/z) calcd (C19Hi702P + H)+ : 309.1039 found: 309.1034; Known compound, Lit. X. Zhang, H. Liu, X. Hu, G. Tang, J. Zhu, Y. Zhao, Org. Lett. 2011, 13, 3478.
Example 15: Triphenylphosphine oxide (14):
Figure imgf000023_0001
2-(trimethylsilyl)phenyl trifluoromethanesulfonate (25 mg, 0.083 mmol), Cesium Fluoride (70 mg, 0.461 mmol), Ethoxydiphenylphosphane (78 mg, 0.33 mmol), Acetonitrile (1 ml): Reaction Time: 16 h; Rf: 0.3 (1 :3 EtOAc:Pet Ether); White Solid; 17.5 mg, 75 %; Ή NMR (400 MHz, CDC13, TMS) δ 7.74-7.63 (m, 6H), 7.59-7.51 (m, 3H), 7.50-7.40 (m, 6H);13C NMR (100 MHz, CDCI3, TMS) δ 132.5 (d, J = 104.0 Hz), 132.1 (d, J = 10.0 Hz), 131.9 (d, J= 2.3 Hz); 128.5 (d, J = 12.4 Hz); 31P NMR (162 MHz, CDC13) δ 29.2; Mass (M + Na)+ 301; Known Compound, Lit. K. Prokop, D. Goldberg, J. Am. Chem. Soc. 2012, 134, 8014.
Example 16: Naphthalen-2-yldiphenylphosphine oxide (15):
Figure imgf000023_0002
l-(trimethylsilyl)naphthalen-2-yl trifluoromethanesulfonate (25 mg, 0.071 mmol), Cesium Fluoride (60 mg, 0.395 mmol), Ethoxydiphenylphosphane (68 mg, 0.287 mmol), Acetonitrile (1 ml): Reaction Time: 16 h; Rf. 0.4 (1 :3 EtOAc:Pet Ether); Thick oil; 19.5 mg, 83 %; Ή NMR (400 MHz, CDCI3, TMS) δ 8.28 ( d, J = 13.8 Hz, 1H), 7.95-7.84 (m, 3H), 7.79-7.40 (m, 13 H); 13C NMR (100 MHz, CDC13, TMS) δ 134.7 (d, J= 2.3 Hz), 134.0 (d, J= 9.3 Hz), 133.0, 132.3, 132.1 (d, J =10.0 Hz), 132.0 (d, J = 1.5 Hz), 131.3 (d, 7 = 243.5 Hz), 128.9, 128.5 (d, J = 12.3 Hz), 128.4, 128.2, 127.4 (d, J = 87.9 Hz), 126.8 (d, J= 10.8 Hz); 3IP NMR (162 MHz, CDC13) δ 29.3; HRMS-ESI (m/z) calcd (C22H17OP + H)+ : 329.1090 found: 329.1086; Known compound, Lit. Y.-L. Zhao, G.-J. Wu, Y. Li, L.-X. Gao, F.-S. Han, Chem. Eur. J. 2012, 18, 9622. ADVANTAGES OF THE INVENTION
1. Raw materials are commercially available and inexpensive
2. One pot process
3. Room temperature process
4. The process is useful in generating chiral phosphine oxides under mild conditions that can serve as precursors to obtain novel aryl-phosphine ligands useful in organic synthesis. .